Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-12-21T23:10:22.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.9%
    Check dated 2024-12-14T22:34:06.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    3%
    Check dated 2024-12-07T14:14:15.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2024-11-30T11:55:15.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.
    Difference
    5%
    Check dated 2024-11-23T04:27:18.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.
    Difference
    4%
    Check dated 2024-11-15T23:06:24.000Z thumbnail image

Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.